Could ketamine boost recovery for critically ill patients on ventilators?
NCT ID NCT07590687
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding low-dose ketamine to standard sedatives helps critically ill patients on breathing machines recover faster and spend more days alive at home. About 640 adults who need unplanned ventilation and sedation will receive either ketamine or a placebo for up to 14 days. Researchers will track outcomes like days at home, brain function, and side effects for 90 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Intensive Care Medicine, APHP.Nord, hôpital Bichat Claude Bernard,
Paris, 75018, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can monitoring brain activity during emergency intubation prevent dangerous blood pressure spikes?
- Reading the blueprint: could Full-Genome sequencing crack Hard-to-Diagnose cases?
- Fiber in feeding tubes may fight superbugs in the ICU
- Ultrasound could replace X-Rays for feeding tube checks in ICU kids
- Which humidifier prevents airway blockages in trauma ICU patients?
- Mapping the waking brain: how ICU patients emerge from sedation